Astria Therapeutics, Inc. Other Research and Development Expense
Astria Therapeutics, Inc. reported Other Research and Development Expense of $15.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2025-03-11
- Astria Therapeutics, Inc. other research and development expense for fiscal 2023 was $15.20M.
| Period end | Other Research and Development Expense 12 month |
|---|---|
| 2023-12-31 | $15.20M 10-K · filed 2025-03-11 |